We are live on
!
Find out more
MIM
Monashee Investment Management Portfolio holdings
AUM
$184M
1-Year Est. Return
197.43%
This Fund
S&P 500
This Quarter
Est. Return
+12.36%
1 Year Est. Return
+197.43%
3 Year Est. Return
+447.04%
5 Year Est. Return
+479.31%
10 Year Est. Return
+5,610.42%
AUM
$525M
AUM Growth
+$163M
(+45%)
Cap. Flow
-$365M
Cap. Flow
% of AUM
-69.47%
Top 10 Holdings %
Top 10 Hldgs %
34.54%
Holding
251
New
–
Increased
–
Reduced
–
Closed
140
Top Buys
No buys this quarter
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SAGE
Sage Therapeutics
SAGE
|
+$17.3M |
| 2 |
General Mills
GIS
|
+$16.1M |
| 3 |
Hilton Grand Vacations
HGV
|
+$13.9M |
| 4 |
Dominion Energy
D
|
+$13.5M |
| 5 |
Arch Capital
ACGL
|
+$12.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.2% |
| 2 | Financials | 16.74% |
| 3 | Technology | 15.78% |
| 4 | Industrials | 10.99% |
| 5 | Energy | 7.71% |
Similar funds
EFIC
SWMG
AAM
IFPL
RFG
KA
KWM
NAM
Monashee Investment Management's Q2 2018 Portfolio in Review
As of Q2 2018, Monashee Investment Management held 251 positions worth $525M, up 45% from $362M the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Monashee Investment Management withdrew a net $365M in Q2 2018, closing 140 positions. Its most notable exit was Sage Therapeutics, an estimated $17.3M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 21% a quarter earlier, followed by Financials and Technology.
- Monashee Investment Management fully exited Sage Therapeutics in Q2 2018, selling an estimated $17.3M.
- Monashee Investment Management's ten largest holdings make up 35% of its $525M portfolio in Q2 2018.
- Monashee Investment Management opened 0 new positions and closed 140 in Q2 2018.
- Monashee Investment Management's portfolio value rose 45% quarter-over-quarter to $525M.
Based on Monashee Investment Management's 13F filing for Q2 2018, filed 10 Aug 2018.